News

(WOODLAND HILLS, CA) – April 9th, 2025 – Scientists at Terasaki Institute for Biomedical Innovation, in collaboration with the University of Maryland School of Pharmacy, have developed a new nanoparticle therapy that tackles obesity through two complementary mechanisms: converting energy-storing white fat into calorie-burning beige fat while simultaneously reducing obesity-related inflammation. Their findings, published in the Journal of Controlled Release, are detailed in an article titled: “Apigenin-loaded nanoparticles for obesity intervention through immunomodulation and adipocyte browning.” This innovative approach addresses key limitations of current obesity treatments by precisely targeting adipose tissue with apigenin-loaded nanoparticles - enhancing therapeutic effects while minimizing potential side effects. A link to the article can be found here.

Read more ...

(WOODLAND HILLS, CA) – March 5-7, 2025 – The Terasaki Institute for Biomedical Innovation (TIBI) hosted its third annual Terasaki Innovation Summit at the Terasaki Institute in Woodland Hills, California. This year's program focused on pioneering advances in biomedical innovation, with a spotlight on micro- and nanotechnologies, diagnostics, therapeutic drug delivery, and regenerative medicine.

Read more ...

Saturday, April 26, 2025 | 10:00 AM | Woodland Hills Campus

The Terasaki Institute for Biomedical Innovation (TIBI) cordially invites you to our upcoming Open House event, where we will showcase the groundbreaking research and innovations being developed within our walls.

Read more ...

Woodland Hills, CA – February 25, 2025– The Terasaki Institute's recent media contest, "Beyond the Horizon: The Future of Bioengineering," drew outstanding entries from across our community, exploring the intersection of art and science. Participants captured scientific phenomena through photography and videography, showcasing everything from intricate patterns in nature to groundbreaking laboratory experiments.

Read more ...

Los Angeles, CA – February 12, 2025—Researchers have achieved a breakthrough in wearable health technology by developing a novel self-healing electronic skin (E-Skin) that repairs itself in seconds after damage. This could potentially transform the landscape of personal health monitoring.

Read more ...

Los Angeles, CA –  February 6, 2025 - The Terasaki Institute for Biomedical Engineering (TIBI) is pleased to announce their selection of Dr. Liangfang Zhang - Irwin Jacobs Chancellor’s Endowed Chair Professor at the University of California San Diego, and Dr. Aydogan Ozcan – Chancellor’s Professor, UCLA & Professor, Howard Hughes Medical Institute (HHMI), as the recipients of the inaugural  Keith Terasaki Mid-Career Innovation Award. These awards will be presented at the 3rd Annual Terasaki Innovation Summit, to be held March 5-7, 2025, at the Terasaki Institute Research Headquarters in Woodland Hills, California.

Read more ...

Los Angeles, CA – February 5th, 2025 -  The Terasaki Institute for Biomedical Engineering (TIBI) is pleased to announce their selection of Dr. Cato Laurencin, Chief Executive Officer, Connecticut Convergence Institute, Professor, University of Connecticut as the recipient of the 2025 Paul Terasaki  Innovation Award and Dr Jun Chen, Associate Professor, Department of Bioengineering, University of California, Los Angeles (UCLA), as the recipient of the 2025 Hisako Terasaki Young Innovator Award.  These awards will be presented at the 3rd Annual Terasaki Innovation Summit, to be held March 5-7, 2025, at the Terasaki Institute Research Headquarters in Woodland Hills, California.

Read more ...

Los Angeles, CA – January 27, 2025 - Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could significantly improve the effectiveness of peptide-based cancer vaccines, according to a new study published in Advanced Functional Materials. The breakthrough centers on a new class of materials called lipopeptide hydrogels (LPHs), which show promise in boosting immune responses and possess adjuvant-like properties.

Read more ...